Loading clinical trials...

Analysis of Postural Transitions in Subjects Affected by Parkinson Disease | Clinical Trials | Clareo Health

COMPLETED

Analysis of Postural Transitions in Subjects Affected by Parkinson Disease

NCT05329987•Fondazione Don Carlo Gnocchi Onlus

Summary

This observational trial aims to evaluate the effect of Rehabilitation on Postural Transfers (PTs) in subjects affected by Parkinson Disease. The PTs are evaluated by an inertial sensor (a device composed by an accelerometer, a gyroscope and a magnetometer) attached to the subjects. The data obtained by the inertial sensor are kinematic (e.g. acceleration and angular speed) and spatiotemporal parameters (e.g. time to completion and velocity). Additional clinical evaluations are carried out at the beginning and end of the rehabilitative intervention.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects with Idiopathic Parkinson's Disease;
•Subjects should be in a positive therapeutic window or in the ON phase during the evaluations;
•Subjects must be able to walk at least 10 meters independently with or without any walking aid

Exclusion Criteria

•Non-clinically stable subjects;
•Subjects in OFF phase during the evaluations;
•Other neurological conditions (e.g. stroke, peripheral neuropathies, etc.);
•Other pathologies that can negatively influence the subject's walking ability (e.g. surgery at the lower limbs in the previous 6 months, important deformities at the lower limbs, etc.)

Locations (1)

Fondazione Don Carlo Gnocchi

Rovato, BS, Italy

Key Dates

Start Date

May 18, 2022

Primary Completion Date

April 1, 2024

Completion Date

August 1, 2024

Last Updated

August 9, 2024

Enrollment

ACTUAL participants

Conditions

Parkinson Disease

Interventions

Rehabilitation

OTHER

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

Autonomic FailurePure Autonomic Failure+3 more

View study

RECRUITINGNA

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

NCT06692920

Parkinson Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Analysis of Postural Transitions in Subjects Affected by Parkinson Disease

Inclusion Criteria

Exclusion Criteria

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Montelukast in Parkinson Disease

Exercise for Cognitive Excellence in Parkinson's Disease

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients